Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy

NCT04815694 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Agostino Gemelli IRCCS as lead sponsor.

NCT NCT04815694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04815694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase
Not applicable
Overall status
Recruiting
Start date
March 17, 2021
Completion date
October 31, 2031
Enrollment
179 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced rectal cancer, neoadjuvant chemoradiotherapy, pathological complete response